What is the debt of Atreca this year?
Atreca has a debt level of -30.8 USD this year.
Atreca Debt 2024
Atreca Debt
-30.8 USD
Ticker
BCEL
ISIN
US04965G1094
WKN
A2PLNM
In 2024, Atreca's total debt was -30.8 USD, a -67.48% change from the -94.7 USD total debt recorded in the previous year.
Atreca Aktienanalyse
What does Atreca do?
Atreca Inc is a biotechnology company that specializes in researching and developing novel immunotherapies for various diseases. It was founded in 2010 by a team of renowned scientists who share a common passion for discovering innovative approaches to treating serious illnesses. The company's business model is based on the identification of antigens - biological molecules that the immune system recognizes and responds to - from the cells of patients suffering from severe diseases such as cancer or autoimmune disorders. Atreca utilizes its proprietary technology platform, called Immune Repertoire Capture (IRC) technology, to isolate and identify these antigens. Once identified, the company can use these antigens to develop new immunotherapies that activate the patient's immune system to fight the disease. These personalized immunotherapies have the potential to be more specific and effective than conventional approaches used on a broad basis. Atreca has split into two main areas to optimize its business model: monetizing research and development and making its technology platform accessible to other companies. The company's research and development department focuses on the discovery and development of personalized immunotherapies for various types of cancer and autoimmune disorders. The company recently entered into a significant milestone agreement with a subsidiary of Merck to develop personalized immunotherapies for selected types of cancer. Atreca also has a separate business unit that provides its IRC technology to other companies. This business unit offers contract research and consulting services to assist other biotechnology and pharmaceutical clients in the identification of antigens and the development of personalized immunotherapies. By providing IRC technology to other companies, Atreca has tapped into a new revenue stream that allows it to offer unique and effective biotechnology solutions in the future. In terms of its products, Atreca has several potential immunotherapy candidates in its pipeline, some of which are already being tested in clinical trials. One of its key products is a personalized immunotherapy drug called ATRC-101, which targets the treatment of patients with metastatic solid tumors. The drug utilizes Atreca's IRC technology to identify the antigens in the patients and develop personalized immunotherapies based on these antigens. Furthermore, the company has additional drug candidates in the development phase and is also considering the possibility of venturing into other disease areas such as infectious diseases. Atreca has the potential to become a key player in the biotechnology industry by providing personalized and effective immunotherapies for a variety of diseases. Atreca ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Atreca's Debt Structure
Atreca's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Atreca's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Atreca’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Atreca’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Atreca stock
What was the debt of Atreca compared to the previous year?
The debt of Atreca has increased by -67.48% compared to the previous year dropped.
What are the consequences of high debt for investors in Atreca?
High debt can pose a risk for investors of Atreca, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Atreca?
Low debt means that Atreca has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Atreca affect the company?
An increase in debt of Atreca can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Atreca affect the company?
A reduction in debt of Atreca can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Atreca?
Some factors that can influence the debt of Atreca include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Atreca so important for investors?
The debts of Atreca are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Atreca take to change the debt?
To change the debt, Atreca can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Atreca pay?
Over the past 12 months, Atreca paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Atreca is expected to pay a dividend of 0 USD.
What is the dividend yield of Atreca?
The current dividend yield of Atreca is .
When does Atreca pay dividends?
Atreca pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Atreca?
Atreca paid dividends every year for the past 0 years.
What is the dividend of Atreca?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Atreca located?
Atreca is assigned to the 'Health' sector.
Wann musste ich die Aktien von Atreca kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Atreca from 9/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/18/2024.
When did Atreca pay the last dividend?
The last dividend was paid out on 9/18/2024.
What was the dividend of Atreca in the year 2023?
In the year 2023, Atreca distributed 0 USD as dividends.
In which currency does Atreca pay out the dividend?
The dividends of Atreca are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Atreca
Our stock analysis for Atreca Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Atreca Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
